Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
Huvudupphovsmän: | Sandham, D, Chen, W, Hardman, C, Luo, J, Xue, L, Ogg, G, Erpenbeck, V |
---|---|
Materialtyp: | Conference item |
Språk: | English |
Publicerad: |
Wiley
2019
|
Liknande verk
Liknande verk
-
Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
av: Chen, W, et al.
Publicerad: (2018) -
Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
av: Xue, L, et al.
Publicerad: (2018) -
Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
av: Hardman, C, et al.
Publicerad: (2019) -
Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)
av: Xue, L, et al.
Publicerad: (2019) -
IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent
av: Hardman, CS, et al.
Publicerad: (2021)